Search Results

• • 1 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• RIPK4 Is an Immune Regulating-Associated Biomarker for Ovarian Cancer and Possesses Generalization Value in Pan-Cancer.

  Authors:Cui Liao, Yi-xia Zhao, Wei-di Han, and Nian-yu LaiFrom:Journal of Immunology Research (Vol. 2022) Peer-Reviewed

  Mar. 9, 20223,598 words Article 1350LOvarian cancer (OC) is the most lethal gynecologic cancer. Many studies have reported that RIPK4 (receptor interacting serine/threonine kinase 4) displayed a dysregulated level in many types of tumors. However, its...